|Title:||Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors|
|Abstract:|| A pharmaceutical formulation comprising the compound of formula ##STR00001##|
|Inventor(s):|| Carter; Malcolm Clive (Stevenage, GB), Cockerill; George Stuart (Stevenage, GB), Lackey; Karen Elizabeth (Durham, NC) |
|Assignee:|| GlaxoSmithKline LLC (Philadelphia, PA) |
|Filing Date:||Jul 16, 2013|
|Claims:||1. A pharmaceutical formulation presented in unit dose form comprising the compound of formula ##STR00055## as an active ingredient, wherein said active ingredient s present within said unit dose form in an amount from 70 mg to 700 mg. |
2. The formulation of claim 1, wherein said unit dose is a tablet.